Here are relevant reports on : mental-health-digital-therapeutics-market
-
Digital Biomarkers Market by Type (Physiological, Vocal, Idiosyncratic), Therapy [Cardio, Onco (Lung, Breast Cancer), Mental Health, Neuro], Application [Clinical Research (Phase IV)], End User (Pharma & Biotech Companies, CROs) – Global Forecast to 2031
The global digital biomarkers market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 19.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Brain Computer Interface Market by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User - Global Forecast to 2029
The global brain computer interface market, valued at US$235 million in 2023, stood at US$262 million in 2024 and is projected to advance at a resilient CAGR of 14.1% from 2024 to 2029, culminating in a forecasted valuation of US$506 million by the end of the period. The growth of this market is driven by the growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable brain computer interface devices, and rising Investments in research and development.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031
The global wearables in pharma & biotech market is projected to reach USD 9.97 billion by 2031, growing at a CAGR of 20.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Mental Health Apps Market by Platform (Android, iOS), Application (Depression, Meditation, Stress, Trauma), Function (Screening, Consultation, Prescription, Treatment, Monitoring, Coaching), End User (Provider, Patient, Employer) - Global Forecast to 2030
The Mental Health Apps market, valued at US$8.21 billion in 2024, stood at US$9.94 billion in 2025 and is projected to advance at a resilient CAGR of 18.0% from 2025 to 2030, culminating in a forecasted valuation of US$22.73 billion by the end of the period. The mental health apps market is growing rapidly, driven by advancements in digital technologies such as artificial intelligence, data analytics, and mobile health platforms.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting & Region - Global Forecast to 2029
The global mental health screening market, valued at US$0.8 billion in 2022, stood at US$0.9 billion in 2023 and is projected to advance at a resilient CAGR of 12.2% from 2023 to 2029, culminating in a forecasted valuation of US$1.8 billion by the end of the period. The growth of this market is driven by the rising awareness of mental health issues, growing geriatric population and subsequent increase in the prevalence of mental disorders, and technological advancements.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Digital Therapeutics Market / DTx Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) - Global Forecast to 2028
The global digital therapeutics market, valued at US$4.4 billion in 2022, stood at US$6.1 billion in 2023 and is projected to advance at a resilient CAGR of 29.1% from 2023 to 2028, culminating in a forecasted valuation of US$21.9 billion by the end of the period. The rapid adoption of digital therapeutics is driven by the rising incidence of chronic diseases, surging investments from venture capital firms, and strategic partnerships between tech companies and healthcare providers.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Personalized Nutrition Market by Product (Products, Services, Digital Tools), Application (General Lifestyle, Beauty, Skin & Longevity, Weight Management & Metabolic Health), End-use, Personalization Basis, Type, & Region - Global Forecast to 2030
The personalized nutrition market is estimated to be USD 15.79 billion in 2025 and is projected to reach USD 30.94 billion by 2030, at a CAGR of 14.4% from 2025 to 2030. The report profiles key players such as Abbott (US), Nestlé Health Science (Switzerland), Medtronic (Ireland), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (USA), Nutrigenomix (Canada), Rootine (US), Sun Genomics (US), etc.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) & Region - Global Forecast to 2028
The global RNA therapeutics market, valued at US$32.2 billion in 2022, stood at US$13.7 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$18.0 billion by the end of the period. Growth in this market is largely driven by factors such as the increasing number of partnerships and collaborations among market players and RNA technology manufacturers, expanding modalities for RNA therapeutics, and the rising number of emergency use authorizations and approvals for COVID-19 booster vaccines.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.
- Published: March 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
